Press Releases (Biological e)

DCGI Approves BE’s 14-Valent Pneumococcal Conjugate Vaccine

1 year ago

Press Release - Biological E. Announces SEC (CDSCO) Recommendation of its 14-Valent Pneumococcal Conjugate Vaccine for Infants

2 years ago

Biological E. Limited reduces CORBEVAX(R) price to Rs.250 a dose

2 years ago

Biological E. Limited Gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate

3 years ago

Biological E. Limited starts Phase I/II clinical trial of its COVID-19 vaccine candidate

3 years ago